Symbol page for $NEVPF (NeuroVive Pharmaceutical AB) including a social stream of SpeculatingStocks pulse posts on NEVPF and various NEVPF stats and sentiment.
Does NeuroVive Pharmaceutical Boast High Insider Ownership? Many investors like to check how much of a company is owned by insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Based on our data, NeuroVive Pharmaceutical insiders have about 1.9% of the stock, worth approximately kr4.4m.
Over the last three years NeuroVive Pharmaceutical AB has seen earnings per share (EPS) move in a positive direction by an average of 43% per year (using a line of best fit). It achieved revenue growth of 47% over the last year. This shows that the company has improved itself over the last few years. This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. Med ”NeuroVive”, ”Bolaget” eller ”Koncernen” avses i detta Prospekt NeuroVive Pharmaceutical AB (publ), org. nr 556595-6538.
Neurovive Pharm Ab Ord stocks price quote with latest real-time prices, charts, NeuroVive Pharmaceutical AB Year End Report January - December 2019 PR 10 Apr 2014 NeuroVive Pharmaceutical AB stock shares were registered with the OTC Reporting Facility for Foreign shares in New York City with the ticker . Contact. Abliva AB (publ) Medicon Village Scheelevägen 2 223 81 Lund, Sweden. Phone +46 (0)46- NeuroVive Pharmaceutical and to-BBB, the Dutch drug brain delivery company, NeuroVive Pharmaceutical AB (publ) shares are listed on the Swedish trading Security and exchange commission filings for NeuroVive Pharmaceutical AB. Insider trades, quarterly, and D. Stock / Securites Offering. 2015-05-26 17:40: 11 Stock news and company filing reports for Abliva AB. NeuroVive Pharmaceutical AB is a leader in mitochondrial medicine, with one project in clinical phase I About NeuroVive Pharmaceutical AB. NeuroVive Pharmaceutical is a pioneer in mitochondrial research and development. The focus is on developing drug 19 Feb 2020 NeuroVive Pharmaceutical AB is a leader in mitochondrial medicine, with one project in clinical phase I (KL1333) for chronic treatment of primary Abliva AB | 1133 followers on LinkedIn. Delivering CFO på Abliva AB (fd NeuroVive Pharmaceutical AB) Venture Capital & Private Equity.
Is NeuroVive Pharmaceutical AB Growing? Over the last three years NeuroVive Pharmaceutical AB has seen earnings per share (EPS) move in a positive direction by an average of 43% per year (using a line of best fit). It achieved revenue growth of 47% over the last year. This shows that the company has improved itself over the last few years.
Köp aktien NeuroVive Pharmaceutical AB (NVP). Hos Nordnet kan du handla från 0 kr i courtage.
NeuroVive Pharmaceutical AB is a leader in mitochondrial medicine, with one project in clinical phase II development for the prevention of moderate to severe traumatic brain injury (NeuroSTAT®) and one project in clinical phase I (KL1333) for genetic mitochondrial diseases.
NeuroVive Pharmaceutical AB is a leader in mitochondrial medicine, with one project in clinical phase I (KL1333) for chronic treatment of primary mitochondrial diseases and one project, in preparation for clinical trials (NV354), for treatment of primary mitochondrial diseases with Complex I deficiency.
Utöver flera viktiga framsteg i utvecklingen av sina projekt och en ny strategi, som innebär att fokus nu ligger på primära mitokondriella sjukdomar med särläkemedelspotential, har man även stärkt finanserna via dubbla emissioner. När BIO-Europe, årets största partnering-konferens på
Bolagets registrerade firma är NeuroVive Pharmaceutical AB (publ) med org.nr 556595 6538. Bolagets handelsbeteckning, det vill säga det namn med vilket Bolaget marknadsför sig, är NeuroVive.
Vardcentralen masen lund
Detaljer. Namn: NeuroVive Pharmaceutical; Typ: Aktie; ISIN: NeuroVive Pharmaceutical är listat på Aktietorget, men förbereder sedan 2011 en flytt till Stockholmsbörsen (Nasdaq OMX Smallcap) under 2012. Uppdatering: I ”NeuroVive Pharmaceutical AB (publ) är verksamt inom området mitokondriell BioStock: Abliva completes phase Ia/Ib study with KL1333, 2021-03-19 11:06. Bolaget gick tidigare under namnet NeuroVive Pharmaceutical.
Market Cap $26.88M. Shares Outstanding 296.34M. Public Float 268.95M. Beta N/A. Rev. per Employee $1,089.5522.
Prijateljstvo slike
buratti rothenberg & burns
stockholms stad betala p
stu-530 g
adun design malmö
restaurang briggen torp uddevalla
skatt sjukersattning
NEVPF: Get the latest Neurovive Pharmaceutical stock price and detailed information including NEVPF news, historical charts and realtime prices.
5 Oct 2018 NeuroVive Pharmaceutical is a Swedish biopharmaceutical company with deep expertise in mitochondrial medicine. NeuroVive shares were listed on Nasdaq Stockholm in April 2013. NeuroVive Pharmaceutical AB 29 Mar 2016 The shareholders of NeuroVive Pharmaceutical AB (publ), corporate re- register their shares in their own name with Euroclear Sweden AB. 31 Mar 2016 the required majority. Approval of the board of directors' resolution to issue shares and warrants with preferential rights for existing shareholders. RaQualia of Japan, CROMA-PHARMA of Austria, Covance of the United States , and NeuroVive Pharmaceutical AB of Sweden and other foreign companies. 10 Feb 2021 Previous assignments: CEO of NeuroVive Pharmaceutical AB. Own and/or related parties' holdings in the company: 755.520 shares.
Köp aktien NeuroVive Pharmaceutical AB (NVP). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid.
2021-03-30 · NeuroVive Pharmaceutical AB shows a slight decrease today, losing -€0.000 (-0.670%) compared to yesterday. The community is currently still undecided about NeuroVive Pharmaceutical AB with 0 Buy predictions and 1 Sell predictions Stock analysis for Abliva AB (NVP) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
NeuroVive har handlats på NASDAQ OMX Stockholm, Small Cap, med kortnamnet NVP.ST sedan april 2013. Kursen för NEVPF-aktien har varierat mellan 4,00 USD och 4,21 USD i USA, vilket motsvarar det svenska marknadsvärdet.